Importantly, tirzepatide may decrease the efficacy of oral contraceptives, particularly during the first 4 weeks after initiation and after each dose escalation
The higher proportion of men vs women in the study may affect the generalisability of the findings to the broader population
Medical criteria for treatment eligibility The FDA guidelines clearly state who can get semaglutide
Unapproved products are risky not only because they havent been reviewed by the FDA, but because theres no way to know their potency, possible contamination, or potential dosing errors
24) in JAMA , begins to close the gap, but more studies are needed to understand the medications' pros and cons for people planning to conceive
So in that 25 years, using frameworks like the phenotypes that you've actually studied, how much success were you able to have with lifestyle-focused treatments